<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35150765</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2742</ISSN><JournalIssue CitedMedium="Internet"><Volume>84</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>The Journal of infection</Title><ISOAbbreviation>J Infect</ISOAbbreviation></Journal><ArticleTitle>Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort study.</ArticleTitle><Pagination><StartPage>566</StartPage><EndPage>572</EndPage><MedlinePgn>566-572</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jinf.2022.02.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0163-4453(22)00065-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">Residual symptoms can be detected for several months after COVID-19. To better understand the predictors and impact of symptom persistence we analyzed a prospective cohort of COVID-19 patients.</AbstractText><AbstractText Label="METHODS">Patients were followed for 9 months after COVID-19 onset. Duration and predictors of persistence of symptoms, physical health and psychological distress were assessed.</AbstractText><AbstractText Label="RESULTS">465 patients (54% males, 51% hospitalized) were included; 37% presented with at least 4 symptoms and 42% complained of symptom lasting more than 28 days. At month 9, 20% of patients were still symptomatic, showing mainly fatigue (11%) and breathlessness (8%). Hospitalization and ICU stay vs. non-hospitalized status increased the median duration of fatigue of 8 weeks. Age &gt; 50 years (OR 2.50), ICU stay (OR 2.35), and presentation with 4 or more symptoms (OR 2.04) were independent predictors of persistence of symptoms at month 9. A total of 18% of patients did not return to optimal pre-COVID physical health, while 19% showed psychological distress at month 9. Hospital admission (OR 2.28) and persistence of symptoms at day 28 (OR 2.21) and month 9 (OR 5.16) were independent predictors of suboptimal physical health, while female gender (OR 5.27) and persistence of symptoms at day 28 (OR 2.42) and month 9 (OR 2.48) were risk factors for psychological distress.</AbstractText><AbstractText Label="CONCLUSIONS">Patients with advanced age, ICU stay and multiple symptoms at onset were more likely to suffer from long-term symptoms, which had a negative impact on both physical and mental wellbeing. This study contributes to identify the target populations and Long COVID consequences for planning long-term recovery interventions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Righi</LastName><ForeName>Elda</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Diagnostics and Public Health Department, Infectious Diseases Division, University of Verona, P.le L.A. Scuro 10, Verona 37134, Italy. Electronic address: elda.righi@univr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mirandola</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Diagnostics and Public Health Department, Infectious Diseases Division, University of Verona, P.le L.A. Scuro 10, Verona 37134, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzaferri</LastName><ForeName>Fulvia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Diagnostics and Public Health Department, Infectious Diseases Division, University of Verona, P.le L.A. Scuro 10, Verona 37134, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dossi</LastName><ForeName>Giuditta</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Diagnostics and Public Health Department, Infectious Diseases Division, University of Verona, P.le L.A. Scuro 10, Verona 37134, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Razzaboni</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Diagnostics and Public Health Department, Infectious Diseases Division, University of Verona, P.le L.A. Scuro 10, Verona 37134, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaffagnini</LastName><ForeName>Amina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Diagnostics and Public Health Department, Infectious Diseases Division, University of Verona, P.le L.A. Scuro 10, Verona 37134, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ivaldi</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Diagnostics and Public Health Department, Infectious Diseases Division, University of Verona, P.le L.A. Scuro 10, Verona 37134, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Visentin</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Diagnostics and Public Health Department, Infectious Diseases Division, University of Verona, P.le L.A. Scuro 10, Verona 37134, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambertenghi</LastName><ForeName>Lorenza</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Diagnostics and Public Health Department, Infectious Diseases Division, University of Verona, P.le L.A. Scuro 10, Verona 37134, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arena</LastName><ForeName>Cinzia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Respiratory Unit, Verona University Hospital, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Micheletto</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Respiratory Unit, Verona University Hospital, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gibellini</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Diagnostics and Public Health Department, Microbiology Unit, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tacconelli</LastName><ForeName>Evelina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Diagnostics and Public Health Department, Infectious Diseases Division, University of Verona, P.le L.A. Scuro 10, Verona 37134, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Infect</MedlineTA><NlmUniqueID>7908424</NlmUniqueID><ISSNLinking>0163-4453</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Infect. 2022 Dec;85(6):702-769. doi: 10.1016/j.jinf.2022.10.005</RefSource><PMID Version="1">36216186</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Infect. 2023 Feb;86(2):154-225. doi: 10.1016/j.jinf.2022.11.009</RefSource><PMID Version="1">36403699</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Infect. 2023 Apr;86(4):e97-e99. doi: 10.1016/j.jinf.2023.02.015</RefSource><PMID Version="1">36803675</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Physical health</Keyword><Keyword MajorTopicYN="N">Predictors</Keyword><Keyword MajorTopicYN="N">Psychological distress</Keyword><Keyword MajorTopicYN="N">Symptom persistence</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors have no competing interests</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>12</Day><Hour>20</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35150765</ArticleId><ArticleId IdType="pmc">PMC8828388</ArticleId><ArticleId IdType="doi">10.1016/j.jinf.2022.02.003</ArticleId><ArticleId IdType="pii">S0163-4453(22)00065-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhang P., Li J., Liu H., et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Bone Res. 2020;8:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7018717</ArticleId><ArticleId IdType="pubmed">32128276</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Tan C., Wu J., et al. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir Res. 2020;21:163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323373</ArticleId><ArticleId IdType="pubmed">32600344</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi&#x2019; A., Barnabei R., Landi F., et al. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y.M., Shang Y.M., Song W.B., et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. eClinicalMedicine. 2020;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Ye L., Xia R., et al. Chest computed tomography and clinical follow-up of discharged patients with COVID-19 in Wenzhou City, Zhejiang, China. Ann Am Thorac Soc. 2020;17:1231&#x2013;1237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7640627</ArticleId><ArticleId IdType="pubmed">32692945</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q., Xu M., Li J., et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2021;27:89&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lorenzo R., Conte C., Lanzani C., et al. Residual clinical damage after COVID-19: a retrospective and prospective observational cohort study. PLOS One. 2020;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7556454</ArticleId><ArticleId IdType="pubmed">33052920</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan F., Ye T., Sun P., et al. Time course of lung changes at chest CT during recovery from COVID-19. Radiology. 2020;295:715&#x2013;721.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233367</ArticleId><ArticleId IdType="pubmed">32053470</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J., Waterboer T., Hippchen T., et al. Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study. Clin Infect Dis. 2021:ciab611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Righi E., Mirandola M., Mazzaferri F., et al. Long-term patient-centred follow-up in a prospective cohort of patients with COVID-19. Infect Dis Ther. 2021;21:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8215633</ArticleId><ArticleId IdType="pubmed">34152573</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao B., Wang J., Wen D. A trial of lopinavir-ritonavir in adults hospitalised with severe Covid-19. N Engl J Med. 2020;382:1787&#x2013;1799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7121492</ArticleId><ArticleId IdType="pubmed">32187464</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahler D.A., Wells C.K. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93:580&#x2013;586.</Citation><ArticleIdList><ArticleId IdType="pubmed">3342669</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadana R., Mathers C.D., Lopez A.D., et al. World Health Organization; Geneva: 2000. Comparative Analyses of More Than 50 Household Surveys on Health Status. GPE discussion Paper No. 15.</Citation></Reference><Reference><Citation>US Department of Health and Human Services . 2nd ed. US Government Printing Office; Washington, DC.: 2000. Healthy People 2010: Understanding and Improving Health.</Citation></Reference><Reference><Citation>Stanford University, SPARQtools, 2022. Self-rated-Health Questionnaire. Available at https://sparqtools.org/mobility-measure/self-rated-health/.</Citation></Reference><Reference><Citation>Kessler R.C., Andrews G., Colpe L.J., et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med. 2002;32:959&#x2013;976.</Citation><ArticleIdList><ArticleId IdType="pubmed">12214795</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC). COVID-19. Risk for COVID-19 Infection, Hospitalization, and Death By Age Group, 2022 Available at www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-age.htlm.</Citation></Reference><Reference><Citation>Yelin D., Wirtheim E., Vetter P., et al. Long-term consequences of COVID-19: research needs. Lancet Infect Dis. 2020;20:1115&#x2013;1117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7462626</ArticleId><ArticleId IdType="pubmed">32888409</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E., Janvier P., Kherabi Y., et al. Post-discharge persistent symptoms and health-related quality of life after hospitalisation for COVID-19. J Infect. 2020;81:e4&#x2013;e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S.J., McIvor J., Whyatt G., et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2020;93:1013&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz Y.M.J., Van Herck M., Delbressine J.M., et al. Persistent symptoms 3&#x2005;months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6:00542&#x2013;02020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C., Laurent E., Lemaignen A., et al. Follow-up of adults with non-critical COVID-19 two months after symptoms' onset. Clin Microbiol Infect. 2021;27:258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Godeau D., Petit A., Richard I., Roquelaure Y., Descatha A. Return-to-work, disabilities and occupational health in the age of COVID-19. Scand J Work Environ Health. 2021;47:408&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8259700</ArticleId><ArticleId IdType="pubmed">34003294</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue J.K., Franko N.M., McCulloch D.J., et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 2021;1</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam M.H., Wing Y.K., Yu M.W., et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169:2142&#x2013;2147.</Citation><ArticleIdList><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson C. Concern coronavirus may trigger post-viral fatigue syndromes. New Sci. 2020;246:10&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194715</ArticleId><ArticleId IdType="pubmed">32372811</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., et al. Attributes and predictors of long COVID. Nat Med. 2021;27:1116.</Citation><ArticleIdList><ArticleId IdType="pubmed">34045738</ArticleId></ArticleIdList></Reference><Reference><Citation>Monaghesh E., Hajizadeh A. The role of telehealth during covid-19 outbreak: a systematic review based on current evidence. BMC Public Health. 2020;20:1193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7395209</ArticleId><ArticleId IdType="pubmed">32738884</ArticleId></ArticleIdList></Reference><Reference><Citation>Cellai M., O'Keefe J.B. Characterization of prolonged COVID-19 symptoms in an outpatient telemedicine clinic. Open Forum Infect Dis. 2020:ofaa420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543492</ArticleId><ArticleId IdType="pubmed">33117851</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M., Braillard O., Chappuis F., Courvoisier D.S., Guessous I. Prevalence of symptoms more than seven months after diagnosis of symptomatic COVID-19 in an outpatient setting. Ann Intern Med. 2021:M21&#x2013;0878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280535</ArticleId><ArticleId IdType="pubmed">34224254</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>